Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 November 2023.Powered by Capital Market - Live News

Net profit of Shukra Pharmaceuticals rose 5787.50% to Rs 4.71 crore in the quarter ended September 2023 as against Rs 0.08 crore during the previous quarter ended September 2022. Sales rose 562.37% to Rs 24.64 crore in the quarter ended September 2023 as against Rs 3.72 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales24.643.72 562 OPM %20.6212.63 - PBDT5.260.46 1043 PBT4.700.01 46900 NP4.710.08 5788 Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News

Shukra Pharmaceuticals announced that the 30th Annual General Meeting (AGM) of the company will be held on 22 September 2023.Powered by Capital Market - Live News

Net profit of Shukra Pharmaceuticals rose 27.27% to Rs 0.42 crore in the quarter ended June 2023 as against Rs 0.33 crore during the previous quarter ended June 2022. Sales rose 206.85% to Rs 20.16 crore in the quarter ended June 2023 as against Rs 6.57 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales20.166.57 207 OPM %1.6914.61 - PBDT0.890.85 5 PBT0.430.43 0 NP0.420.33 27 Powered by Capital Market - Live News